Evaluation of Binding Property of Remusatia vivipara (Roxb) Mucilage in Tablet Formulation
Mayur R. Bhurat1,2*and Dr. S. D. Barhate1
1Shree Sureshdada Jain Institute of Pharmaceutical Education and
Research, Jammer
2J.J.T. University,
Zunzunu, Rajasthan
*Corresponding Author E-mail: bhuratmayur@gmail.com
ABSTRACT:
Remusatia vivipara is a
common herbaceous belongs to the family of Araceae.
Tubers of plant contain mucilage hence attempt to evaluate the tubers for
suitability as tablet binder is considered and the present investigation repots
the isolation of mucilage of Remusatia vivipara tubers. The DSC and FTIR thermograms
of drug and mucilage indicated no chemical interaction. Phytochemical and
Physiochemical characteristics of mucilage were studied which confirmed the
mucilage nature. The mucilage was evaluated for its granulating and binding
properties in compressed tablet using Metformin HCl as model drug. The granules prepared by mucilage with
different concentration such as 1%, 3%, 5% and 10% were compared with starch
paste, which was used as standard binder. The tablets had good physiochemical
properties and the drug release was more than 95% within 24hr. It was observed
that decreasing the concentration of mucilage increases hardness and the
disintegration time. The tablet prepared using 1% and 3% shows drug release
rate in sustained manner and that of standard binder 10% starch paste used for
comparison. Remusatia vivipara
mucilage could be used as a good binding agent at very low concentrations. This
can be used for sustaining the drug release from tablets, since the prepared
tablets produced a sticky film of hydration on the surface, which ultimately
reduces drug release rate and hence it can be evaluated for its efficacy to
sustain the drug release.
KEY
WORDS: Remusatia vivipara, Mucilage,
Binder.
INTRODUCTION:
Medicinal
plants constitute main source of new pharmaceuticals and healthcare products.
The family Araceae, commonly known as aroids consists
of 105 genera and more than 3300 species. (Bhurat M.
R. et al., 2011) Excipients are the additives used to
convert active pharmaceutical ingredients into pharmaceutical dosage form
suitable for administration to patients (Kibbe A.H.,
et al., 2000). New and improved excipients continue
to be developed to meet the needs of conventional drug delivery systems and to
meet the needs of advanced tablet manufacturing. Mucilage and gums have been
known since ancient times for their medicinal uses. In the modern era also they
widely used in pharmaceutical industries as tablet binders, emulsions and
thickeners in cosmetics and suspensions as film-forming agents and traditional
colloids (Monif T., et al.,1992, Kapoor
V.P., etal., 1992).
Hence the
demand for these substances is increasing and new sources are getting tapped (Kakrani H.K., et al., 1981, Bhunvara
N.S., et al., 1985). Though, India, due to geographical and environmental
positioning has traditionally been a good source for such products among the
Asian countries, a large quantity of this still being imported from the
European countries to meet up the ever- increasing demand (Kulkarni
G. T., et al., 2002).
Remusatia vivipara Roxb.
Family Araceae is terrestrial herb with fleshy subglobose tubers. The plant has been used medicinally for
anti inflammatory, analgesic, antioxidant, depressant etc. (Bhura
M. R. et al., 2011, D. Asha et al., 2013, Bhurat
M. R., 2011) In the present study an effort was made to extract the mucilage
from the tubers of Remusatia vivipara Roxb. Family Araceae and investigate the pharmaceutical
properties of the mucilage to assess its suitability as an excipient
in the pharmaceutical formulation. Here the potential binding capacity of the
mucilage has been evaluated with the standard starch paste as a tablet binder.
Materials
and Method Plant Procurement and Authentication of plants
The plant
was collected from Toranmal, Dist. Nandurbar in the month of October. The plant was
authenticated by Dr. Tanvir A. Khan, Department of
Botany, M. J. College, Jalgaon, Maharashtra.
Materials
Metformin
hydrochloride obtained as gift sample from Lupin
pharmaceuticals, Aurangabad. Mucilage extracted from tubers and talc,
magnesium. stearate, lactose
obtained as gift sample from In care pharmaceuticals, Aurangabad.
Extraction
Methodology
The tubers
are separated from plant and then tubers are washed and clean with water. Then
tubers are then cut into slices then dried in sunlight and then grind it to
convert it into powder form.
Isolation of mucilage:
The tubers
of Remusatia vivipara(100gm) were soaked in distilled water for 24 hour, boiled
for 1 hour and kept aside for 2 hour to release mucilage in to water. The
material was squeezed in a muslin bag to remove the marc from the filtrate.
Then, equal volume of acetone was added to filtrate to precipitate the
mucilage. The mucilage was separated, dried in oven at temperature less than
50°C, powdered and passed through sieve number 80. The powder was stored in desiccator until further use. (Trease
G.E.et al., 2003)
Purification of mucilage:
The
mucilage is purified by shaking in beaker on shaker with Ethanol. Percentage
yield was Found to be 30.02%.
Evaluation
of mucilage for flow properties
The
mucilage was evaluated for flow properties using Tapped density, Bulk density, Angle
of repose, Hausner’s ratio, Carr’s index.It was found to be good to flow.( Martin A.et
al.,2008) It was calculated by following formulae-1) Tapped density=Mass/Tapped
volume 2) Bulk density= Mass/volume 3) Angle of repose (ø) =1/tan h/r4) Hausner’s ratio= Tapped density/ Bulk density 5) Carr’s
index= Tapped density- Bulk density/ Tapped density.
Preparation
of granules
Lactose and
starch powder were passed through sieve No: 40. Metformin
IP was mixed with lactose and starch powder and was homogeneously dry-mixed.
The granules prepared by wet granulation method using Remusatia vivipara mucilage and starch binders in
concentration of 1%, 3%,5% and 10%. the moistened
friable mass was passed through sieve No: 16 and granules were dried at 50°C
for 30 min. the dried granules were re-sieved through sieve No: 20.(I.P., 1996,
Martin A.et al., 2008)
Evaluation
of granules for flow properties
The
granules were evaluated for flow properties using Tapped density. Bulk density, Angle of repose, Hausner’s
ratio, Carr’s index. It was found to be good to flow. (Martin A.et al.,
2008) It was calculated as above mentioned in evaluation of mucilage.
Preparation
of tablets
Magnesium stearate and talc were mixed with prepared granules. This
uniformly mixed blend was compressed into 300 mg tablets using flat face round
tooling on a Jaguar rotary tablet machine by using RVM as 1%, 3%, 5% , 10%
& S.P.. The tablets were stored in tightly closed glass container and
evaluated for following parameters. (Martin A.et al., 2008, I.P., 1996)
Evaluation
of prepared tablets
Compressed
tablets were then evaluated for shape, diameter and thickness, weight
variation, disintegration, hardness, friability study. Diameter and thickness
were measured by using Vernier Caliper. Hardness was
measured by Monsanto type hardness tester. Friability was determined in friabilator (Electrolab EF-2,
USP). For disintegration test, one tablet was placed in each tube of
disintegration apparatus (Electrolab ED-2L, USP) and
the test was carried out using distilled water as a disintegrating media.(I.P., 1996)
In Vitro
Dissolution Studies
Release of Metformin from the tablets was studied using a six basket
IP I dissolution apparatus taking 900 ml of phosphate buffer (pH 6.8) for 24 h.
The dissolution media were maintained at a temperature of 37±0.5°C.The speed of
rotation of basket was maintained at 50 rpm. The basket was covered with 100
mesh nylon cloth to prevent the escape of the beads. The samples were withdrawn
at specified intervals. The samples were filtered by Whatman filter paper No.41
and suitably diluted to determine the absorbance at 233 nm using UV/ Visible
single-beam spectrophotometer (Electrolab, Mumbai,
India). The in vitro dissolution
rates were further tested using pharmacokinetic models. The % of drug released
vs. time (zero order release plot) was shown in fig. (I.P.1996)
Drug-excipient compatibility and FTIR studies
This study
has been done to check whether there is any compatibility related problems are
associated with drug and excipients used for the
formulation of tablet. The drug and excipients must
be compatible with one another to produce a product that is stable,
efficacious, attractive and easy to administer and safe. If the excipients are new and not been used in formulations containing
the active substance, the compatibility studies are of paramount importance.
Thermal analysis and FTIR can be used to investigate and predict any
physicochemical interactions between components in a formulation and can
therefore be applied to the selection of suitable chemically compatible excipients. (Beckett A.H.et al., 2004,
Sharma Y.R.et al., 2009). The IR spectral analysis of a drug and other excipients were taken using Press pellet technique (using KBr). The IR spectra’s were determined by using Shimadzu 8400S,
USA FTIR (Beckett A.H.et al., 2004, Sharma Y.R.et al., 2009)
Table
No.1
|
Sr. no. |
Ingredients |
RVM 1% |
RVM 3% |
RVM 5% |
RVM 10% |
Std S.P. 10% |
|
1 |
Metformin |
150mg |
150mg |
150mg |
150mg |
150mg |
|
2 |
RVM |
3gm |
9mg |
15mg |
30mg |
- |
|
3 |
Powder Starch |
20mg |
20mg |
20mg |
20mg |
20mg |
|
4 |
Lactose |
115mg |
109mg |
103mg |
88mg |
88mg |
|
5 |
Talc |
6mg |
6mg |
6mg |
6mg |
6mg |
|
6 |
Magnesium Stearate |
6mg |
6mg |
6mg |
6mg |
6mg |
|
7 |
Starch Paste |
- |
- |
- |
- |
30mg |
|
8 |
Total Weight |
300mg |
300mg |
300mg |
300mg |
300mg |
Differential
Scanning Calorimeter Studies (DSC)
DSC was
performed on a Shimadzu DSC-60 (Shimadzu Limited Japan). A 1:1 ratio of drug
and excipient was weighed into aluminum crucible and
sample was analyzed by heating at a scanning rate of 100C/min over a
temperature range 200-3000C under a nitrogen flow of 40ml/ min. Reproducibility
was checked by running the sample in triplicate18.( Beckett A.H.et al.,2004,
Sharma Y.R.et al.,2009)
Formulation
of tablets
Tablets
were formulated with different concentration of mucilage as 1%, 3%, 5%, 10% and
S.P. and other excipients are given in table 1.
Phytochemical
analysis
The
presence of carbohydrate and mucilage was substantiated with the positive
result upon the treatment with Molisch’s Test
(formation of purple color) and Ruthenium red test (formation of pink color on powdered
particles), respectively.
Flow
Property of Mucilage
By studying
various parameters for flow property it was found that mucilage is good to flow
and values are shown in table 2.
Table.2
- Flow Property of Mucilage
|
Sr .No. |
Properties |
Values |
|
1 |
Bulk density
g/cm3 |
0.62±0.01 |
|
2 |
Tapped density
g/cm3 |
0.74±0.03 |
|
3 |
Carr’s index
(%) |
15.18±1.67 |
|
4 |
Hausner’s
ratio |
1.26±0.09 |
|
5 |
Angle of
repose |
25.99±1.82 |
All
values are expressed in mean. (n=3)
Flow
Property of Prepared Granules
By studying
various parameters for flow property it was found that granules is good to flow
and values are shown in table 3.
Table .3
Flow properties of prepared granules
|
Sr .No. |
Properties |
Values |
|
1 |
Bulk density
g/cm3 |
0.60±0.02 |
|
2 |
Tapped density
g/cm3 |
0.71±0.03 |
|
3 |
Carr’s index
(%) |
14.98±1.35 |
|
4 |
Hausner’s
ratio |
1.11±0.05 |
|
5 |
Angle of
repose |
24.40±1.60 |
All
values are expressed in mean. (n=3)
Evaluation
of tablets
After
studying the chemical-chemical interaction the mucilage was selected as tablet
binder in the formulation of Metformine tablets, and
the tablets were formulated with various percentages of this mucilage. The
standard binder starch paste was also used for the comparison study (Table-4).
The physical tests for all the formulated tablets were shown in Table-4. All
the batches of tablets exhibited the diameter and thickness, uniformity in
weight, hardness and friability values were within the pharmacopoeial
limits.
In-vitro
release study
The
in-vitro dissolution profile of with different concentrations of Remusatia vivipara mucilage
and Starch paste is shown in Figure. (Figure no.1) It was found that release of
drug from tablet using RVM is extended as compared to tablet using starch
paste. Also found that as concentration of mucilage is increased the release of
drug is also extends. Table no. 5 shows the % drug release drug with different
concentration of mucilage and starch paste used as standard for comparison.
Name of
the Drug = Metformin
Loading
Dose in mg = 150mg
Volume of
Dissolution Medium (ml)
= 900
Volume of
Sample removed (ml)
= 1
Dilution
Factor
= 10
Table No.4 - Comparison of evaluation of formulated Metformin tablets using RVM and starch binders (SP)
|
Formulations |
Diameter (mm) |
Thickness (mm) |
Weight Variation (mg) |
Disintegration Time (min) |
Hardness (Kg/cm) |
Friability %±SD |
|
RVM 1% |
9±0.1256 |
4±0.1798 |
300.1±0.0163 |
41±0.89 |
4±0.2840 |
0.6±0.29 |
|
RVM 3% |
9±0.1389 |
4±0.1814 |
299.5±0.0178 |
32±0.32 |
4±0.3211 |
0.5±0.07 |
|
RVM 5% |
9±0.1651 |
4±0.1428 |
301.3±0.0398 |
30±0.55 |
4±0.4512 |
0.4±0.12 |
|
RVM 10% |
9±0.1421 |
4±0.0934 |
301.2±0.0772 |
24±0.49 |
4±0.2431 |
0.5 ±0.08 |
|
STD. S.P. 10% |
9±0.1181 |
4±0.1054 |
299.9±0.1643 |
23±0.34 |
4±0.1298 |
0.5 ±0.11 |
All values are expressed in mean. (n=3)
% DRUG
RELEASE
Fig. No. 1- Comparison of In vitro drug release from tablets
prepared using different concentration of RVM and Std. Starch Paste
Drug-excipient compatibility study
The FTIR spectra
of the mixture of drug and mucilage revealed that there was no major physical
and chemical interaction between the drug and mucilage which is shown in
figure. (Figure no. 2 and 3)
Figure No.2 - IR analysis of Metformin
Figure No.3 - IR analysis of RVM and Metformin
Table
No. 5- Comparative effects of different concentration levels of Remusatia vivipara mucilage
and Standard Starch Paste used as the binding agents on the release rate of Metformin tablets
|
TIME (HOUR) |
RVM 1% |
RVM 3% |
RVM 5% |
RVM 10% |
STD.S.P. 10% |
|
0 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.5 |
39.522 |
43.993 |
31.869 |
32.155 |
40.592 |
|
1 |
43.411 |
46.239 |
34.361 |
33.578 |
66.939 |
|
2 |
50.180 |
57.104 |
44.635 |
42.827 |
73.411 |
|
4 |
53.564 |
62.553 |
50.178 |
47.883 |
78.792 |
|
6 |
67.195 |
63.829 |
57.088 |
57.566 |
82.951 |
|
8 |
72.375 |
76.351 |
72.041 |
63.736 |
92.672 |
|
10 |
80.006 |
82.208 |
80.346 |
74.599 |
95.683 |
|
12 |
87.00 |
91.347 |
84.696 |
78.236 |
99.407 |
|
14 |
93.00 |
94.291 |
87.805 |
83.687 |
- |
|
16 |
97.086 |
98.273 |
95.463 |
87.334 |
- |
|
18 |
99.430 |
98.381 |
96.430 |
90.274 |
- |
|
20 |
- |
- |
- |
94.348 |
- |
|
22 |
- |
- |
- |
95.452 |
- |
|
24 |
- |
- |
- |
96.555 |
- |
All
values are expressed in mean. (n=3)
Differential Scanning Calorimetry
The DSC thermogram
of pure drug, drug with mucilage and blank mucilage were shown in figure
(Figure no. 4 and 5). The thermogram of metformin hydrochloride exhibited sharp endothermic peak at
232C indicated melting point which was reported in literature. Characteristic
peak of metformin hydrochloride was well recognized
in the drug with mucilage. Thus there was no interaction between metformin hydrochloride and mucilage, Further; the decrease
in sharpness of metformin hydrochloride endothermic
peak in drug with mucilage may be due to the conversion of crystalline form of metformin hydrochlo- ride to
amorphous form.
Figure No.4 - DSC of Metformin
Figure No.5- DSC of RVM and Metformin
CONCLUSION:
As per
Pharmacopoeia, It was found that the tablets prepared using 1%,3%,5% & 10% w/ v concentration of Isolated Remusatia vivipara mucilage
passes disintegration test, hardness test and other evaluation tests for
tablets. The formulations have enough hardness to withstand the mechanical
shocks of handling in manufacturing and packing. Taking all the above
parameters into consideration, the study has revealed a good potential of Remusatia vivipara mucilage
as a binder for conventional tablet formulations. From the present
investigation, it can be concluded that the mucilage of Remusatia vivipara can be used in low concentration
as a binder in comparison with standard binder. The results suggested that RVM
could be a potential binder in low concentration level. It can also be used for
sustaining the drug release from tablets at lower concentration. Also from In
vitro dissolution profile it is conclude that tablets prepared using RVM
10% shows extended release of drug as compared to tablets prepared using starch
paste of same strength as standard binder. From this study it is conclude that
tablet prepared with 10% RVM shows extended drug release that is for 24 hours
as compared to 10% standard S.P which
for 12 hours.
REFERENCES:
1.
Bhurat M.
R., Sapakale H. S., Salunkhe
K.G., Sanghavi R. S., Kawatikwar
P.S., Asian Journal of Biochemical and
Pharmaceutical Research 2011a,
2, 303-306.
2.
Bhurat
M.R.; Bagad Y.M.; Waghmare
R.U.; Wankhede U.W.; Salunkhe
P.S., IJPS’s Journal of Pharmacology
and Toxicology 2011b,
1, 61-66.
3.
Bhurat M.
R., International Journal of Current Pharmaceutical Research ,
Vol 3, issue 1, 2011.
4.
D. Asha, M. S. Nalini and M. D. Shylaja†
Scholars Research Library Der Pharmacia Lettre, 2013, 5 (5):120-128
5.
Monif. T, Mahlhtra AK. Kapoor VP. Indian J.
Pharm Sci 1992; 54:
234-240. 3. Kapoor VP, Banerji
R, Prakash D. J SciInd Res
1992; 51:1-22.
6.
Kakrani
HK, Jain NK. Indian J Hosp Pharm 1981; 100-102.
7.
Bhunvara
NS, Khorana ML. Indian Drugs 1985; 22:500-502.
8.
Kulkarni.
GT, Gowthamarajan K, Rao
BG, Suresh. B. Indian Drugs 2002, 38, 422-468.
9.
Kulkarni
G.T. Gowthamarajan K. Rao
B.G. and Suesh B., Evaluation of binding properties
of Plantago ovata and Trigonella foenumgraecum
mucilages, Indian drugs, 2002, 39(8), 422-425.
10. Sharma Y.R., Element organic Spectroscopy,
4th edition, Chand S Publication: New
Delhi, 2009, 132-133.
11. Beckett A.H. and Stenlake
J.B., Practical Pharmaceutical chemistry, Part 2. CBS Publication: New Delhi,
2004, 383-389.
12. Indian Pharmacopeia, Ministry of health and
family welfare, New Delhi, 1996, 2, 710,711, A- 89,A-95, A-114-115, A-80.
13. Aulton M.E., Powder flow, In:
Pharmaceutics-The design and manufacture of medicines. London New York: Churchill
Livingstone, 2007, 176.
14. Martin A. Swarbrick
J. and Cammarata A., Micromeritics,
In: Physical Pharmacy and Pharmaceutical Sciences, 5th edition, New Delhi: Wolters Kluwer publication, 2008,
492.
15. Khandelwal. K.R, Nirali Prakashan, Practical Pharmacognosy, Techniques and
Experiments, 2002, 9th edition, pp 149-156.
16. Evaluation of honey locust (GleditsiatriacanthosLinn.)
gum as sustaining material in tablet dosage forms, Melike
Üner, Turan Altýnkurt Department of Pharmaceutical Technology, Faculty
of Pharmacy, Istanbul University, Beyazýt, Istanbul
34119, Turkey, Elsevier Publication, April 2004.
17. Trease G.E. and Evans W.C., “Pharmacognosy”,
William and Wilkins Co., Baltimore, USA, 14th Ed, 2003 P-349,351.
18. Kokate C.K., “Practical Pharmacognosy”, 3rd Ed, Vallabh Prakashan, Delhi, 1991,
PP-107-109.
19. Mukarjee P., “Quality Control of Herbal Drugs”, 1st
Ed, Business horizon, New Delhi, 2002, PP- 370-381.
20. Anroop, B., Bhatnagar,
S.P., Ghosh, B., Parcha,
V., 2005. Studies on Ocimum grattisimum
seed mucilage: evaluation of suspending properties. Ind. J. Pharm. Sci. 67,
206–209.
21.
Baveja,
S.K., Rangarao, K.V., Jagdish,
A., 1998. Examination of natural gums and mucilages
as sustaining materials in tablet dosage forms. Ind. J. Pharm. Sci. 50, 89–92.
22. Monif, T., Malhotra,
A.K., Kapoor, V.P., 1992. Cassia fissula
seed galactomanan: potential binding agent for pharmaceutical
formulation. Ind. J. Pharm. Sci. 54, 234–240.
23.
Girish K Jani, Dhiren P Shah, Vipul D Prajapati, Vineet C Jain, Gums and mucilages:
versatile excipients for pharmaceutical formulations,
Asian Journal of Pharmaceutical Sciences 2009, 4 (5): 309-323
24. Kibbe AH, editor. Handbook of Pharmaceutical Excipient. London (UK); The
Pharmaceutical Press: 2000, 3, 43-55.
25.
King’s
American Dispensatory, 1898.
26.
http://www.henriettesherbal.com/
Received on 21.11.2014 Accepted on 11.01.2015
© Asian Pharma
Press All Right Reserved
Asian J. Pharm.
Tech. 2015; Vol. 5: Issue 1, Pg 23-28
DOI: 10.5958/2231-5713.2015.00005.7